Exciting study management opportunity with our reputable global CRO aligned with a global exciting sponsor.
What you will be doing :
- Supports country SSU strategy in close collaboration with Study Start-Up Team Lead, Country Head Portfolio / Cluster Head Portfolio
- Collaborates with Country / Cluster Head Portfolio, Portfolio Team Leads and global study team to ensure SSU timelines and deliverables are met according to country commitments
- Accountable for timely start-up activities from country allocation until Green Light (ready to initiate site milestone) in assigned projects
- Ensures close collaboration with local IRBs / IECs and Health Authorities, as applicable
- Ensures that study start-up activities are conducted and completed on time, including preparation of IRB / IEC submission packages, review of Informed Consent Forms, engaging Regulatory Affairs / CTA Hub for Health Authorities submissions, as required
- Prepares and finalizes local submission package for submission to IRB / IEC, CTA Hub (Europe: according to new EU-CTR) as well as Health Authorities as applicable (including subsequent amendments, IBs, DSURs, CSRs)
- Coordinates timely response to deficiency letters in close collaboration with local and global stakeholders
- Coordinates reportable events and notifications to IRB / IEC and Health Authorities as applicable
- Accountable for timelines, accuracy, and quality of country TMF documents in study start-up to ensure TMF inspection readiness
- Ensures adherence to financial standards, prevailing legislation, ICH / GCP, IRB / IEC, Health Authority, and SOP requirements
- Implements innovative and efficient processes aligned with client strategy
- Supports study feasibility in collaboration with Feasibility Manager and Site Partnership Manager as well as the global study team
- Leads site selection in collaboration with Portfolio Team Lead and Clinical Project Manager if already assigned
- In satellite countries, oversees local vendor selection and performance as needed. Serves as main contact for quality / compliance issues in SSU phase, escalating as necessary
- Ensures sites are prepared for “Green Light” and all documentation is in place for initial and subsequent drug release. Responsible for review and sign off of the site “Green Light”
- Oversees local SSU team activities to achieve start-up timelines and quality execution, proposing and implementing corrective actions where appropriate, according to client standards and regulations
- Leads / chairs local SSU team meetings, participates in global study team meetings as required
- Leads the development of country site initiation and patient enrolment plans with SSU CRA, CPM, and others
You are :
- Minimum 5 years’ experience in clinical operations overseeing project management and/or monitoring clinical trials
- Capable of leading in a matrix environment, without direct reports
- Understanding of all aspects of clinical drug development, especially trial setup, execution, and monitoring
- Strong project management skills with problem-solving and mediation abilities
- Thorough knowledge of international drug development standards (GCP / ICH), health authorities (FDA / EMA), and local regulations
- Strong interpersonal, negotiation, and conflict resolution skills
- Effective communication in a local / global matrixed environment
- Fully bilingual in French and English (spoken and written)
What ICON can offer you :
Our success depends on the quality of our people. We prioritize building a diverse culture that rewards high performance and nurtures talent.
In addition to a competitive salary, ICON offers various benefits focused on well-being and work-life balance, including:
- Various annual leave entitlements
- Health insurance options for you and your family
- Retirement planning offerings
- Global Employee Assistance Program, TELUS Health, with 24/7 access to support professionals
- Life assurance
- Flexible country-specific benefits such as childcare vouchers, bike schemes, gym discounts, travel passes, health assessments, and more
At ICON, inclusion & belonging are fundamental. We are committed to providing an accessible, discrimination-free workplace. All qualified applicants will receive equal consideration without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or veteran status.